stomach cancer

Shared gastric adenocarcinoma tumor features seem to span geography and ethnicity, despite shifts in the proportion of tumors from different molecular subtypes.

Under the deal, the parties will provide Perthera's Precision Cancer Analysis molecular profiling service to Hope for Stomach Cancer patients free of charge.

The Danish firm received FDA clearance to expand the intended use of its HercepTest and HER2 FISH pharmDx Kit to include patients with metastatic gastric or stomach cancer.

Industry observers have noted that the move from the outspoken Billy Tauzin, also known as the "Swamp Fox," to an insider business lobbyist-type like Castellani represents a shift in PhRMA's advocacy style. Where that leaves PhRMA's support for personalized medicine, a pet cause of Tauzin's, is hard to determine in the post-healthcare-reform climate in Washington.

New Releases

Premium

Dako's HercepTest and HER2 FISH pharmDx, Pathway Genomics' Genetic Health Report

Genentech will work with Dako in filing for clearance of the HercepTest and HER2 FISH pharmDx as companion diagnostics for Herceptin in treating patients with stomach cancer.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.